About
Liquid Biopsy
Areas of Focus
Categories
DiagnosticsNJ, NY, PA
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
4
As Collaborator
0
Total Enrollment
834
By Status
COMPLETED: 3TERMINATED: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Today
Hover over trial bars to see details
Recent Trials
NCT05437679Lead Sponsor
Characterization of Circulating Tumor Cells (CTCs) in High Risk and Early Metastatic Prostate Cancer Patients Using Parsortix® System
N/ATerminated
9 participants
Started: Jul 5, 2022 · Completed: Aug 22, 2023
NCT03427450Lead Sponsor
Harvest of CTCs From MBC Patients Using the Parsortix™ PC1 System
N/ACompleted
421 participants
Started: Mar 29, 2018 · Completed: Dec 31, 2019
NCT02785731Lead Sponsor
Evaluation of Multiple Biomarkers to Estimate Risk of Ovarian Cancer in Patients With a Pelvic Mass.
N/ACompleted
204 participants
Started: Jul 14, 2016 · Completed: Jul 31, 2018
NCT02781272Lead Sponsor
Evaluation of Multiple Protein and Molecular Biomarkers to Estimate Risk of Cancer in Gynecology Patients Presenting With a Pelvic Mass.
N/ACompleted
200 participants
Started: Jun 30, 2016 · Completed: Jun 27, 2022
Locations (1)
Headquarters
Plymouth Meeting, PA, United States
Map
Loading map...